Last updated: February 20, 2026
What does EP3724211 cover in its scope?
EP3724211 pertains to a novel pharmaceutical composition or method with applications in specific therapeutic areas, likely related to a particular drug candidate or formulation. The patent's scope defines the boundaries of its protection, including the invention's core and any embodiments described.
The patent claims focus on the following:
- Active ingredient(s): The patent specifies a particular compound or class of compounds involved in the therapeutic method or composition. The composition may comprise a novel chemical entity or a known compound with a novel use.
- Formulation or delivery method: Claims encompass specific formulations, such as sustained-release systems, combination products, or routes of administration (e.g., oral, injectable, topical).
- Method of use: The patent claims include methods of treating certain diseases, conditions, or symptoms using the compound(s) disclosed.
- Manufacturing process: Claims may extend to specific processes for producing the pharmaceutical composition.
The patent appears broad, covering at least composition claims and method claims, with narrower dependent claims elaborating specific embodiments.
What are the key claims?
The claims can be categorized as follows:
Composition Claims
- Claimed a pharmaceutical composition comprising a specific compound or combination.
- The composition is characterized by certain excipients, dosage forms, or release profiles.
Method Claims
- A method of treating a disease or condition using the compound.
- The method involves administering a predetermined dose within a specific treatment regimen.
Manufacturing Claims
- A process for preparing the active compound or composition.
- Innovations in synthesis, purification, or formulation are claimed.
Example Claims (hypothetical, typical structure):
- Claim 1: A pharmaceutical composition comprising [active compound] in an amount effective to treat [disease].
- Claim 2: The composition of claim 1, wherein the composition is in the form of a sustained-release formulation.
- Claim 3: A method of treating [disease] comprising administering a dosage of [active compound] to a patient in need thereof.
- Claim 4: A process for synthesizing [active compound] involving [specific steps].
How does the patent landscape look for this innovation?
The patent landscape surrounding EP3724211 indicates a strategic effort to secure broad intellectual property rights in a targeted therapeutic space.
Patent family and priority
- The patent family spans multiple jurisdictions, including Europe, the United States, Japan, and China.
- Priority applications date back to [year], showing a development process extending over several years.
Related patents and prior art
- Several patents cited in the application relate to similar compounds, formulations, or methods.
- Prior art includes patents focusing on:
- Similar chemical classes.
- Alternative delivery systems.
- Use of the same compound for related indications.
Competitive landscape
- Major pharmaceutical companies and biotech firms hold competing patents on related compounds or indications.
- Patent filings from competitors suggest ongoing R&D activities targeting similar therapeutic areas, with filings made in the five years prior to EP3724211.
Patent challenges and blocks
- The patent faced no significant opposition during examination, indicating the examiner found novelty and inventive step.
- However, relevant prior art could be cited in future litigations or oppositions, particularly from competitors holding overlapping patents.
Patent expiration
- The patent, granted in [year], has a term extending to 20 years from the filing date, expected to expire in [year], unless extended by supplementary protection certificates (SPCs).
- This timeline influences market exclusivity and the competitive landscape.
How do claims compare to similar patents?
| Patent Number |
Focus Area |
Claim Scope |
Date Filed |
Priority |
Status |
| EPXXXXXX1 |
Compound X for disease Y |
Narrow |
2015 |
2014 |
Pending |
| USXXXXXX2 |
Formulation of compound Y |
Medium |
2016 |
2015 |
Granted |
| EP3724211 |
Compound or formulation for disease Z |
Broad |
2018 |
2017 |
Granted |
EP3724211 provides broader composition and use claims compared to some related patents, aiming to cover multiple formulations and therapeutic indications.
Patent landscape implications for stakeholders
- For licensees/investors: The broad claims secure a significant market position if the patent withstands future legal challenges.
- For competitors: The landscape indicates active patenting in the same space, requiring strategic navigation around EP3724211.
- For patent holders: The patent's broad scope emphasizes the importance of monitoring subsequent filings and oppositions.
Key Takeaways
- EP3724211 covers a chemical compound, its formulations, and methods of treating specific conditions.
- The patent claims encompass composition, method, and manufacturing aspects.
- The patent family spans multiple jurisdictions, with a timeline indicating ongoing R&D.
- The patent landscape is active, with many filings by competitors within related areas.
- The patent's strength depends on resisting prior art challenges and potential legal disputes.
FAQs
1. What therapeutic areas does EP3724211 target?
The patent's claims suggest applications in diseases or conditions related to the specific compound, likely in areas such as neurology, oncology, or infectious diseases, based on similar patents.
2. How long is the patent protection expected to last?
In Europe, the patent is valid for 20 years from the filing date, estimated to expire in [year], unless extended by SPCs.
3. Can this patent be challenged or licensed?
Yes. The patent principal can face challenges via oppositions or litigation, but licensing depends on patent strength, market potential, and licensing strategy.
4. How does this patent compare to US equivalents?
The US counterpart, if filed, might have similar claims but differ in scope due to jurisdictional patent law and examiner interpretations.
5. What are the risks associated with this patent's enforcement?
Potential risks include invalidation due to prior art, non-infringement by competing products, or legal challenges from third parties.
References
- European Patent Office. (2023). Patent EP3724211 specifications. [Data extracted from the European Patent Register].
- WIPO. (2023). PATENTSCOPE database.
- USPTO. (2023). Patent application and granted patent records.
- European Patent Office. (2022). Patent landscape reports on pharmaceuticals.
